Balaxi Pharmaceuticals Limited has informed the Exchange regarding a board meeting held on February 9, 2024, where they approved the unaudited financial results for the quarter and nine months ended December 31, 2023, and discussed the update on their pharmaceutical formulation plant in Hyderabad.